Sitagliptin Teva 100 mg filmom obložene tablete
| Name | Sitagliptin Teva 100 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-646716317 |
| Active Substance | sitagliptinmalat |
| Composition | jedna tableta sadrži 100 mg sitagliptina u obliku sitagliptinmalata |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Teva Gyogyszergyar Zrt., Debrecen, Mađarska
Teva Operations Poland Sp. z o.o., Krakow, Poljska Merckle GmbH, Blaubeuren, Baden-Wuerttemberg, Njemačka Teva Pharma B.V., Haarlem, Nizozemska Actavis International Ltd., Luqa, Malta Balkanpharma - Dupnitsa AD, Dupnitsa, Bugarska |
| Marketing Authorisation Holder | Teva B.V., Swensweg 5, Haarlem, Nizozemska |
| Marketing Authorisation Date | 18.06.2021 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/20-02/134 |
| Registration Number | 381-12-01/154-21-02 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | A10BH01 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
